Handelsbanken Fonder Ab Jazz Pharmaceuticals PLC Transaction History

Handelsbanken Fonder Ab

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$126.59 - $161.18 $97,980 - $124,753	-774 Reduced 2.25%	33,657 $4.49 Million
Q2 2022 Aug 03, 2022	SELL	$141.59 - $168.66 $2.9 Million - $3.45 Million	-20,479 Reduced 37.3%	34,431 $5.37 Million
Q1 2022 May 11, 2022	SELL	$129.64 - $160.7 $379,974 - $471,011	-2,931 Reduced 5.07%	54,910 $8.55 Million
Q4 2021 Feb 08, 2022	BUY	$119.87 - $145.67 $771,603 - $937,677	6,437 Added 12.52%	57,841 $7.37 Million
Q3 2021 Nov 10, 2021	BUY	$128.64 - $184.79 $354,017 - $508,542	2,752 Added 5.66%	51,404 $6.69 Million
Q2 2021 Aug 03, 2021	BUY	$160.2 - $186.42 $5.42 Million - $6.3 Million	33,807 Added 227.73%	48,652 $8.64 Million
Q1 2021 Apr 29, 2021	BUY	$150.19 - $173.5 $47,309 - $54,652	315 Added 2.17%	14,845 $2.44 Million
Q4 2020 Feb 11, 2021	BUY	$140.71 - $165.05 $77,249 - $90,612	549 Added 3.93%	14,530 $2.4 Million
Q2 2020 Aug 26, 2020	BUY	$95.68 - $121.88 $1.34 Million - $1.7 Million	13,981 New	13,981 $1.54 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.